US FDA Approves Expanded Use of Otezla, Psoriasis Drug of Amgen
The company ‘Amgen’ has announced that, the Food and Drug Administration (FDA) of the United States has authorized the drug ‘Otezla’ for the purpose of treating the adult patients with plaque psoriasis, which are the candidates for the systematic therapy. With the help of the indication of expansion, the Otezla
Read More